This approval makes Lutathera the first therapy specifically reviewed ... that in adults for the approved dose. Lutathera (lutetium Lu 177 dotatate) is approved in the US for adults and children ...

This image shows the first human therapy with Lu-177-labeled PSMA-617. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing ...

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera ... version of Lutathera (lutetium Lu 177 dotatate) to the US market.

PURPOSE: Molecular radiotherapy is a treatment modality that is highly suitable for targeting micrometastases and [177Lu]Lu-DOTATATE is currently being explored as a potential novel treatment ...

USAN: lutetium Lu 177 dotatate/INN: lutetium (177Lu) oxodotreotide, (Lutathera®) belongs to an emerging form of treatments called Peptide Receptor Radionuclide Therapy (PRRT), which involves ...